GI Adverse Events Up With GLP-1 Receptor Agonists

Share this content:
GI Adverse Events Up With GLP-1 Receptor Agonists
GI Adverse Events Up With GLP-1 Receptor Agonists

TUESDAY, Nov. 15, 2016 (HealthDay News) -- Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are associated with increased risk of gastrointestinal adverse events (AEs), with risk varying based on dose, background medications, and type of GLP-1 RA, according to research published online Nov. 9 in Diabetes, Obesity and Metabolism.

Karolin Bettge, from St. Josef Hospital in Bochum, Germany, and colleagues conducted a systematic literature review and selected 32 phase 3 clinical trials with GLP-1 RAs. They analyzed the proportion of patients reporting nausea, vomiting, or diarrhea for different doses and glucose-lowering background medications.

The researchers observed a dose-dependent risk for nausea for long-acting agents and across all GLP-1 RAs (P = 0.0063 and 0.0017, respectively); a similar trend was seen for vomiting (P = 0.23). There was a dose-dependent risk for diarrhea (P = 0.031). More nausea and vomiting were seen for background treatment with metformin (P = 0.04 and 0.0009, respectively). Less nausea and less diarrhea were seen for lixisenatide versus exenatide (twice/day). The risk was similar for dulaglutide and liraglutide, while less risk was seen for exenatide and albiglutide versus liraglutide. Compared with short-acting agents, long-acting GLP-1 RAs correlated with less nausea and vomiting but more diarrhea.

"GLP-1 RAs are associated with gastrointestinal AEs that are related to dose and background medications (especially metformin), and may vary in a compound-specific manner," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Study Provides Estimates of U.S. Prevalence of Type 1, 2 Diabetes

Study Provides Estimates of U.S. Prevalence of Type ...

Prevalence of type 1 diabetes 0.5 percent, type 2 diabetes 8.5 percent among U.S. adults

Black Individuals at Highest Risk of Legal Intervention Injury

Black Individuals at Highest Risk of Legal Intervention ...

Increase in rates of injuries from 2005 to 2009, followed by a drop to 2015, returning to ~2005 levels

Research Links Doctor Burnout to Patient Safety Incidents

Research Links Doctor Burnout to Patient Safety Incidents

Physician burnout linked to increased risk of patient safety incidents, reduced patient satisfaction

is free, fast, and customized just for you!




Already a member?

Sign In Now »